NewcelX ( NCEL ) announced on Wednesday that it has entered into securities purchase agreements for a private placement at a purchase price of $2.75 per share, representing a 30% premium to the last closing price of the company’s common shares on March 31, 2026. Pursuant to the terms of the securities purchase agreements, the company is selling an aggregate of 490,907 common shares (and common sha...
NewcelX ( NCEL ) announced on Wednesday that it has entered into securities purchase agreements for a private placement at a purchase price of $2.75 per share, representing a 30% premium to the last closing price of the company’s common shares on March 31, 2026. Pursuant to the terms of the securities purchase agreements, the company is selling an aggregate of 490,907 common shares (and common share equivalents) and one series of warrants to purchase an aggregate of 687,270 common shares at $3.025 per share. The offering includes participation from existing shareholders and is expected to close on or about April 15, 2026. The company intends to use the net proceeds from the offering, together with its previously announced $25M equity line, to advance NCEL-101, NewcelX’s lead program for Type 1 Diabetes, in collaboration with Eledon Pharmaceuticals, its other development pipeline programs, working capital, and general corporate purposes. NCEL +7.07% premarket to $2.27. Source: Press Release More on NLS Pharmaceutics Financial information for NLS Pharmaceutics
Viridian Therapeutics (VRDN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Viridian Therapeutics (VRDN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Immunic ( IMUX ) on Wednesday said it has received written notice from Nasdaq, informing that it has regained compliance with the minimum bid price requirement as the closing bid price of the company's common stock was at $1.00 per share or greater for at least 20 consecutive business days, satisfying the Nasdaq requirement on March 26, 2026. IMUX +5.4% premarket to $1.17. Source: Press Release Mo...
Immunic ( IMUX ) on Wednesday said it has received written notice from Nasdaq, informing that it has regained compliance with the minimum bid price requirement as the closing bid price of the company's common stock was at $1.00 per share or greater for at least 20 consecutive business days, satisfying the Nasdaq requirement on March 26, 2026. IMUX +5.4% premarket to $1.17. Source: Press Release More on Immunic Immunic garners new Buy at Guggenheim on lead asset Immunic rises after $400M private placement, leadership transition Seeking Alpha’s Quant Rating on Immunic Historical earnings data for Immunic Financial information for Immunic
Rhythm Pharmaceuticals (RYTM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Rhythm Pharmaceuticals (RYTM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
(RTTNews) - The U.K. stock market's benchmark index FTSE 100 moved up sharply on Wednesday thanks to fairly strong buying across the board amid growing optimism about a de-escalation in tensions in the Middle East. Stocks from banking, mining and travel sectors moved up sharply.
(RTTNews) - The U.K. stock market's benchmark index FTSE 100 moved up sharply on Wednesday thanks to fairly strong buying across the board amid growing optimism about a de-escalation in tensions in the Middle East. Stocks from banking, mining and travel sectors moved up sharply.
InTest Corporation ( INTT ) announced on Wednesday that Rich Rogoff , division president of InTest’s environmental technologies division, has also been named president and chief executive officer of InTest Corporation and appointed to the InTest board of directors, replacing Nick Grant, who has served as president, CEO, and board member since 2020, effective immediately. Rogoff joined InTest in Oc...
InTest Corporation ( INTT ) announced on Wednesday that Rich Rogoff , division president of InTest’s environmental technologies division, has also been named president and chief executive officer of InTest Corporation and appointed to the InTest board of directors, replacing Nick Grant, who has served as president, CEO, and board member since 2020, effective immediately. Rogoff joined InTest in October 2021 as vice president of corporate development. In that role he led InTest’s acquisitions of Acculogic, Videology and Alfamation and on an interim basis ran InTest’s process technologies and environmental technologies divisions before being promoted to division president of environmental technologies in June 2025. Earlier in his career, Rogoff spent seven years at Onto Innovation and one of its predecessor companies as vice president and business unit manager of Lithography Systems and then vice president of Strategic Initiatives and Integration Management Office. Before that, he spent more than 20 years at ASML. Source: Press Release More on inTest InTEST outlines $125M–$130M 2026 revenue target amid backlog growth and diversification strategy inTest Non-GAAP EPS of $0.16 beats by $0.05, revenue of $32.8M beats by $1.57M Seeking Alpha’s Quant Rating on inTest
UAE Poised To Join Anti-Iran Operations, As Trump Rips NATO 'Paper Tiger' - Says Exit 'Beyond Reconsideration' Summary UAE mulls becoming first Gulf country to directly joint US-Israeli war against Iran, lobbies for firm UNSC security resolution. Trump open to exiting 'paper tiger' NATO after Iran war is over, angry over lack of help in Hormuz crisis. Oil tanker leased to QatarEnergy was struck by...
UAE Poised To Join Anti-Iran Operations, As Trump Rips NATO 'Paper Tiger' - Says Exit 'Beyond Reconsideration' Summary UAE mulls becoming first Gulf country to directly joint US-Israeli war against Iran, lobbies for firm UNSC security resolution. Trump open to exiting 'paper tiger' NATO after Iran war is over, angry over lack of help in Hormuz crisis. Oil tanker leased to QatarEnergy was struck by an Iranian cruise missile in Qatari waters Wednesday. IRGC has newly vowed to keep attacking with "full intensity and power" - suggesting this is far from over, as ceasefire talks remain theater lacking in much substance. Ayatollah praises Hezbollah in written statement. * * * First Gulf Country to Directly Join War? The small but wealthy country of United Arab Emirates appears to be edging toward open confrontation, with Arab officials saying it is preparing to join the US and allied powers in forcibly reopening the Strait of Hormuz after absorbing Iranian strikes. If so, the move would mark the first time a Persian Gulf state formally enters the conflict as a combatant. Behind the scenes Abu Dhabi is reportedly pushing hard at the UN, lobbying for a Security Council resolution to legitimize military action, while simultaneously urging Washington and its European and Asian partners to assemble a coalition willing to act, according to The Wall Street Journal . At the same time, the UAE is quietly assessing what it can bring to the fight, from mine-clearing operations to broader logistical and naval support aimed at securing the vital shipping lane. But the ambitions don't stop there, amid an opportunity to settle old grievances and a territory dispute. Gulf sources say the Emiratis are also floating a far more aggressive idea: that the US should seize key islands in the waterway, including Abu Musa - held by Iran for decades but claimed by the UAE. However, the fine print is important here ... Headline: The UAE is “ready to join the fight” to open Strait of Hormuz! Article...